Novo Nordisk A/S, on April 2, 2024, reported it began a share repurchase program on February 6, 2024, planning to buy back up to DKK 20 billion worth of shares, having repurchased 1,550,500 B shares valued at DKK 1.34 billion so far. The program aims to enhance shareholder value and currently represents 1.1% of its total share capital.